But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

There is no single test to diagnose schizophrenia. Healthcare professionals may use a variety of tests to rule out other ...

Despite the challenges, many individuals with schizophrenia can lead fulfilling lives with the right treatment and support.

About one-third of patients with schizophrenia do not respond to conventional medications, leaving them with one effective ...

Results show that cognitive decline, combined with factors like smoking, obesity, and chronic health conditions, sharply ...

Research indicates that pneumonia occurs in 30% and intestinal blockage in 5% of schizophrenia patients on clozapine, ...

I'm an Ivy League student at Columbia with schizophrenia, which causes hallucinations. I always see eels and lemons, so it's ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

Lower cognitive functioning in schizophrenia is linked to a higher risk of early death Smoking, obesity, and autoimmune ...

In the complex landscape of mental health research, a new viewpoint offers a critical examination of how genes and ...

KarXT, a novel schizophrenia drug, is on the verge of FDA approval, promising to revolutionize treatment. However, access ...

(TEVA), presented data informing clinical strategies for switching patients to UZEDY, an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for the ...